Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 1495
Single User License Price INR 106474
Corporate User License Price USD 4485
Corporate User License Price INR 319422
Site License Price USD 2990
Site License Price INR 212948
Request a Quote

Report Title

Generics Global Group of Eight (G8) Industry Guide 2017-2021

Quote Request for License Type
License Type Price  
Single User License USD 1495
Site License USD 2990
Enterprise Wide License USD 4485
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Generics Global Group of Eight (G8) Industry Guide 2017-2021


Quote Request for License Type
License Type Price  
Single User License USD 1495
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Generics Global Group of Eight (G8) Industry Guide 2017-2021

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Generics Global Group of Eight (G8) Industry Guide 2017-2021



Executive Summary

Generics Global Group of Eight (G8) Industry Guide 2017-2021

Summary

The G8 Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the G8 generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

The G8 countries contributed USD1,89,457.1 million in 2016 to the global generics industry, with a compound annual growth rate (CAGR) of 8.4% between 2012 and 2016. The G8 countries are expected to reach a value of USD2,68,983.2 million in 2021, with a CAGR of 7.3% over the 2016-21 period.

Among the G8 nations, the US is the leading country in the generics industry, with market revenues of USD1,01,790.0 million in 2016. This was followed by Japan and Germany, with a value of USD45,850.0 and USD18,657.1 million, respectively.

The US is expected to lead the generics industry in the G8 nations with a value of USD1,48,130.6 million in 2016, followed by Japan and Germany with expected values of USD62,926.8 and USD22,373.1 million, respectively.

Scope

Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 generics market

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 generics market

Leading company profiles reveal details of key generics market players' G8 operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the G8 generics market with five year forecasts by both value and volume

Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country

Reasons to buy

What was the size of the G8 generics market by value in 2016?

What will be the size of the G8 generics market in 2021?

What factors are affecting the strength of competition in the G8 generics market?

How has the market performed over the last five years?

How large is the G8 generics market in relation to its regional counterparts?

Table of Contents

Introduction

What is this report about?

Who is the target reader?

How to use this report

Definitions

Group of Eight (G8) Generics

Industry Outlook

Generics in Canada

Market Overview

Market Data 20

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in France

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in Germany

Market Overview

Market Data

Market Segmentation 50

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in Italy

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in Japan

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in Russia

Market Overview

Market Data 90

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in The United Kingdom

Market Overview

Market Data

Market Segmentation

Market outlook

Five forces analysis

Macroeconomic indicators

Generics in The United States

Market Overview

Market Data

Market Segmentation 120

Market outlook

Five forces analysis

Macroeconomic indicators

Company Profiles

Leading Companies

Appendix

Methodology

About MarketLine

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Figure 1: G8 generics industry, revenue(USDm), 2012-21

Figure 2: G8 Generics industry, revenue by country (%), 2016

Figure 3: G8 generics industry, revenue by country (USDm), 2012-16

Figure 4: G8 generics industry forecast, revenue by country (USDm), 2016-21

Figure 5: Canada generics market value: USD million, 2012-16

Figure 6: Canada generics market volume: % of total pharma volume, 2012-16

Figure 7: Canada generics market geography segmentation: % share, by value, 2016

Figure 8: Canada generics market value forecast: USD million, 2016-21

Figure 9: Canada generics market volume forecast: % of total pharma volume, 2016-21

Figure 10: Forces driving competition in the generics market in Canada, 2016

Figure 11: Drivers of buyer power in the generics market in Canada, 2016

Figure 12: Drivers of supplier power in the generics market in Canada, 2016

Figure 13: Factors influencing the likelihood of new entrants in the generics market in Canada, 2016

Figure 14: Factors influencing the threat of substitutes in the generics market in Canada, 2016

Figure 15: Drivers of degree of rivalry in the generics market in Canada, 2016

Figure 16: France generics market value: USD million, 2012-16

Figure 17: France generics market volume: % of total pharma volume, 2012-16

Figure 18: France generics market geography segmentation: % share, by value, 2016

Figure 19: France generics market value forecast: USD million, 2016-21

Figure 20: France generics market volume forecast: % of total pharma volume, 2016-21

Figure 21: Forces driving competition in the generics market in France, 2016

Figure 22: Drivers of buyer power in the generics market in France, 2016

Figure 23: Drivers of supplier power in the generics market in France, 2016

Figure 24: Factors influencing the likelihood of new entrants in the generics market in France, 2016

Figure 25: Factors influencing the threat of substitutes in the generics market in France, 2016

Figure 26: Drivers of degree of rivalry in the generics market in France, 2016

Figure 27: Germany generics market value: USD million, 2012-16

Figure 28: Germany generics market volume: % of total pharma volume, 2012-16

Figure 29: Germany generics market geography segmentation: % share, by value, 2016

Figure 30: Germany generics market value forecast: USD million, 2016-21

Figure 31: Germany generics market volume forecast: % of total pharma volume, 2016-21

Figure 32: Forces driving competition in the generics market in Germany, 2016

Figure 33: Drivers of buyer power in the generics market in Germany, 2016

Figure 34: Drivers of supplier power in the generics market in Germany, 2016

Figure 35: Factors influencing the likelihood of new entrants in the generics market in Germany, 2016

Figure 36: Factors influencing the threat of substitutes in the generics market in Germany, 2016

Figure 37: Drivers of degree of rivalry in the generics market in Germany, 2016

Figure 38: Italy generics market value: USD million, 2012-16

Figure 39: Italy generics market volume: % of total pharma volume, 2012-16

Figure 40: Italy generics market geography segmentation: % share, by value, 2016

Figure 41: Italy generics market value forecast: USD million, 2016-21

Figure 42: Italy generics market volume forecast: % of total pharma volume, 2016-21

Figure 43: Forces driving competition in the generics market in Italy, 2016

Figure 44: Drivers of buyer power in the generics market in Italy, 2016

Figure 45: Drivers of supplier power in the generics market in Italy, 2016

Figure 46: Factors influencing the likelihood of new entrants in the generics market in Italy, 2016

Figure 47: Factors influencing the threat of substitutes in the generics market in Italy, 2016

Figure 48: Drivers of degree of rivalry in the generics market in Italy, 2016

Figure 49: Japan generics market value: USD billion, 2012-16

Figure 50: Japan generics market volume: % of total pharma volume, 2012-16

Figure 51: Japan generics market geography segmentation: % share, by value, 2016

Figure 52: Japan generics market value forecast: USD billion, 2016-21

Figure 53: Japan generics market volume forecast: % of total pharma volume, 2016-21

Figure 54: Forces driving competition in the generics market in Japan, 2016

Figure 55: Drivers of buyer power in the generics market in Japan, 2016

Figure 56: Drivers of supplier power in the generics market in Japan, 2016

Figure 57: Factors influencing the likelihood of new entrants in the generics market in Japan, 2016

Figure 58: Factors influencing the threat of substitutes in the generics market in Japan, 2016

Figure 59: Drivers of degree of rivalry in the generics market in Japan, 2016

Figure 60: Russia generics market value: USD million, 2012-16

Figure 61: Russia generics market volume: % of total pharma volume, 2012-16

Figure 62: Russia generics market geography segmentation: % share, by value, 2016

Figure 63: Russia generics market value forecast: USD million, 2016-21

Figure 64: Russia generics market volume forecast: % of total pharma volume, 2016-21

Figure 65: Forces driving competition in the generics market in Russia, 2016

Figure 66: Drivers of buyer power in the generics market in Russia, 2016

Figure 67: Drivers of supplier power in the generics market in Russia, 2016

Figure 68: Factors influencing the likelihood of new entrants in the generics market in Russia, 2016

Figure 69: Factors influencing the threat of substitutes in the generics market in Russia, 2016

Figure 70: Drivers of degree of rivalry in the generics market in Russia, 2016

Figure 71: United Kingdom generics market value: USD million, 2012-16

Figure 72: United Kingdom generics market volume: % of total pharma volume, 2012-16

Figure 73: United Kingdom generics market geography segmentation: % share, by value, 2016

Figure 74: United Kingdom generics market value forecast: USD million, 2016-21

Figure 75: United Kingdom generics market volume forecast: % of total pharma volume, 2016-21

Figure 76: Forces driving competition in the generics market in the United Kingdom, 2016

Figure 77: Drivers of buyer power in the generics market in the United Kingdom, 2016

Figure 78: Drivers of supplier power in the generics market in the United Kingdom, 2016

Figure 79: Factors influencing the likelihood of new entrants in the generics market in the United Kingdom, 2016

Figure 80: Factors influencing the threat of substitutes in the generics market in the United Kingdom, 2016

Figure 81: Drivers of degree of rivalry in the generics market in the United Kingdom, 2016

Figure 82: United States generics market value: USD billion, 2012-16

Figure 83: United States generics market volume: % of total pharma volume, 2012-16

Figure 84: United States generics market geography segmentation: % share, by value, 2016

Figure 85: United States generics market value forecast: USD billion, 2016-21

Figure 86: United States generics market volume forecast: % of total pharma volume, 2016-21

Figure 87: Forces driving competition in the generics market in the United States, 2016

Figure 88: Drivers of buyer power in the generics market in the United States, 2016

Figure 89: Drivers of supplier power in the generics market in the United States, 2016

Figure 90: Factors influencing the likelihood of new entrants in the generics market in the United States, 2016

Figure 91: Factors influencing the threat of substitutes in the generics market in the United States, 2016

Figure 92: Drivers of degree of rivalry in the generics market in the United States, 2016

Figure 93: STADA Arzneimittel AG: revenues & profitability

Figure 94: STADA Arzneimittel AG: assets & liabilities

Figure 95: Sanofi SA: revenues & profitability

Figure 96: Sanofi SA: assets & liabilities

Figure 97: Sawai Pharmaceutical Co., Ltd.: revenues & profitability

Figure 98: Sawai Pharmaceutical Co., Ltd.: assets & liabilities

Figure 99: Daiichi Sankyo Co., Ltd.: revenues & profitability

Figure 100: Daiichi Sankyo Co., Ltd.: assets & liabilities

Figure 101: Abbott Laboratories: revenues & profitability

Figure 102: Abbott Laboratories: assets & liabilities

Figure 103: Krka, d. d., Novo mesto: revenues & profitability

Figure 104: Krka, d. d., Novo mesto: assets & liabilities

Figure 105: Mylan N.V.: revenues & profitability

Figure 106: Mylan N.V.: assets & liabilities

Figure 107: Novartis AG: revenues & profitability

Figure 108: Novartis AG: assets & liabilities

Figure 109: Teva Pharmaceutical Industries Limited: revenues & profitability

Figure 110: Teva Pharmaceutical Industries Limited: assets & liabilities

 

List of Tables

Table 1: G8 generics industry, revenue(USDm), 2012-21

Table 2: G8 generics industry, revenue by country (USDm), 2012-16

Table 3: G8 generics industry forecast, revenue by country (USDm), 2016-21

Table 4: Canada generics market value: USD million, 2012-16

Table 5: Canada generics market volume: % of total pharma volume, 2012-16

Table 6: Canada generics market geography segmentation: USD million, 2016

Table 7: Canada generics market value forecast: USD million, 2016-21

Table 8: Canada generics market volume forecast: % of total pharma volume, 2016-21

Table 87: Canada size of population (million), 2012-16

Table 88: Canada gdp (constant 2005 prices, USD billion), 2012-16

Table 89: Canada gdp (current prices, USD billion), 2012-16

Table 90: Canada inflation, 2012-16

Table 91: Canada consumer price index (absolute), 2012-16

Table 92: Canada exchange rate, 2012-16

Table 9: France generics market value: USD million, 2012-16

Table 10: France generics market volume: % of total pharma volume, 2012-16

Table 11: France generics market geography segmentation: USD million, 2016

Table 12: France generics market value forecast: USD million, 2016-21

Table 13: France generics market volume forecast: % of total pharma volume, 2016-21

Table 14: France size of population (million), 2012-16

Table 15: France gdp (constant 2005 prices, USD billion), 2012-16

Table 16: France gdp (current prices, USD billion), 2012-16

Table 17: France inflation, 2012-16

Table 18: France consumer price index (absolute), 2012-16

Table 19: France exchange rate, 2012-16

Table 20: Germany generics market value: USD million, 2012-16

Table 21: Germany generics market volume: % of total pharma volume, 2012-16

Table 22: Germany generics market geography segmentation: USD million, 2016

Table 23: Germany generics market value forecast: USD million, 2016-21

Table 24: Germany generics market volume forecast: % of total pharma volume, 2016-21

Table 25: Germany size of population (million), 2012-16

Table 26: Germany gdp (constant 2005 prices, USD billion), 2012-16

Table 27: Germany gdp (current prices, USD billion), 2012-16

Table 28: Germany inflation, 2012-16

Table 29: Germany consumer price index (absolute), 2012-16

Table 30: Germany exchange rate, 2012-16

Table 31: Italy generics market value: USD million, 2012-16

Table 32: Italy generics market volume: % of total pharma volume, 2012-16

Table 33: Italy generics market geography segmentation: USD million, 2016

Table 34: Italy generics market value forecast: USD million, 2016-21

Table 35: Italy generics market volume forecast: % of total pharma volume, 2016-21

Table 36: Italy size of population (million), 2012-16

Table 37: Italy gdp (constant 2005 prices, USD billion), 2012-16

Table 38: Italy gdp (current prices, USD billion), 2012-16

Table 39: Italy inflation, 2012-16

Table 40: Italy consumer price index (absolute), 2012-16

Table 41: Italy exchange rate, 2012-16

Table 42: Japan generics market value: USD billion, 2012-16

Table 43: Japan generics market volume: % of total pharma volume, 2012-16

Table 44: Japan generics market geography segmentation: USD billion, 2016

Table 45: Japan generics market value forecast: USD billion, 2016-21

Table 46: Japan generics market volume forecast: % of total pharma volume, 2016-21

Table 47: Japan size of population (million), 2012-16

Table 48: Japan gdp (constant 2005 prices, USD billion), 2012-16

Table 49: Japan gdp (current prices, USD billion), 2012-16

Table 50: Japan inflation, 2012-16

Table 51: Japan consumer price index (absolute), 2012-16

Table 52: Japan exchange rate, 2012-16

Table 53: Russia generics market value: USD million, 2012-16

Table 54: Russia generics market volume: % of total pharma volume, 2012-16

Table 55: Russia generics market geography segmentation: USD million, 2016

Table 56: Russia generics market value forecast: USD million, 2016-21

Table 57: Russia generics market volume forecast: % of total pharma volume, 2016-21

Table 58: Russia size of population (million), 2012-16

Table 59: Russia gdp (constant 2005 prices, USD billion), 2012-16

Table 60: Russia gdp (current prices, USD billion), 2012-16

Table 61: Russia inflation, 2012-16

Table 62: Russia consumer price index (absolute), 2012-16

Table 63: Russia exchange rate, 2012-16

Table 64: United Kingdom generics market value: USD million, 2012-16

Table 65: United Kingdom generics market volume: % of total pharma volume, 2012-16

Table 66: United Kingdom generics market geography segmentation: USD million, 2016

Table 67: United Kingdom generics market value forecast: USD million, 2016-21

Table 68: United Kingdom generics market volume forecast: % of total pharma volume, 2016-21

Table 69: United Kingdom size of population (million), 2012-16

Table 70: United Kingdom gdp (constant 2005 prices, USD billion), 2012-16

Table 71: United Kingdom gdp (current prices, USD billion), 2012-16

Table 72: United Kingdom inflation, 2012-16

Table 73: United Kingdom consumer price index (absolute), 2012-16

Table 74: United Kingdom exchange rate, 2012-16

Table 75: United States generics market value: USD billion, 2012-16

Table 76: United States generics market volume: % of total pharma volume, 2012-16

Table 77: United States generics market geography segmentation: USD billion, 2016

Table 78: United States generics market value forecast: USD billion, 2016-21

Table 79: United States generics market volume forecast: % of total pharma volume, 2016-21

Table 80: United States size of population (million), 2012-16

Table 81: United States gdp (constant 2005 prices, USD billion), 2012-16

Table 82: United States gdp (current prices, USD billion), 2012-16

Table 83: United States inflation, 2012-16

Table 84: United States consumer price index (absolute), 2012-16

Table 85: United States exchange rate, 2012-15

Table 86: Apotex, Inc.: key facts

Table 93: Les Laboratoires Servier: key facts

Table 94: STADA Arzneimittel AG: key facts

Table 95: STADA Arzneimittel AG: key financials (USD)

Table 96: STADA Arzneimittel AG: key financials (�)

Table 97: STADA Arzneimittel AG: key financial ratios

Table 98: Sanofi SA: key facts

Table 99: Sanofi SA: key financials (USD)

Table 100: Sanofi SA: key financials (�)

Table 101: Sanofi SA: key financial ratios

Table 102: Sawai Pharmaceutical Co., Ltd.: key facts

Table 103: Sawai Pharmaceutical Co., Ltd.: key financials (USD)

Table 104: Sawai Pharmaceutical Co., Ltd.: key financials (�)

Table 105: Sawai Pharmaceutical Co., Ltd.: key financial ratios

Table 106: Daiichi Sankyo Co., Ltd.: key facts

Table 107: Daiichi Sankyo Co., Ltd.: key financials (USD)

Table 108: Daiichi Sankyo Co., Ltd.: key financials (�)

Table 109: Daiichi Sankyo Co., Ltd.: key financial ratios

Table 110: Abbott Laboratories: key facts

Table 111: Abbott Laboratories: key financials (USD)

Table 112: Abbott Laboratories: key financial ratios

Table 113: Krka, d. d., Novo mesto: key facts

Table 114: Krka, d. d., Novo mesto: key financials (USD)

Table 115: Krka, d. d., Novo mesto: key financials (�)

Table 116: Krka, d. d., Novo mesto: key financial ratios

Table 117: Mylan N.V.: key facts

Table 118: Mylan N.V.: key financials (USD)

Table 119: Mylan N.V.: key financial ratios

Table 120: Novartis AG: key facts

Table 121: Novartis AG: key financials (USD)

Table 122: Novartis AG: key financial ratios

Table 123: Teva Pharmaceutical Industries Limited: key facts

Table 124: Teva Pharmaceutical Industries Limited: key financials (USD)

Table 125: Teva Pharmaceutical Industries Limited: key financial ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person